Yen-Wan Hsiao

Title: Innovations of Yen-Wan Hsiao

Introduction

Yen-Wan Hsiao is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of probiotic compositions and screening methods for hybridomas. With a total of 2 patents, his work has the potential to impact cancer treatment and antibody development.

Latest Patents

One of Yen-Wan Hsiao's latest patents is a probiotic composition for preventing, improving, or alleviating pancreatic cancer and its complications. This invention focuses on a specific probiotic composition that can significantly improve various symptomatic indicators and the severity of pancreatic cancer. The method involves using an oral composition that includes specific strains in a defined ratio.

Another significant patent is a screening method for the rapid identification of hybridomas. This method utilizes cell size and the expression of an exogenous label, such as fluorescence labeling, to streamline the antibody development process. By reducing the time required compared to traditional methods, this innovation represents a substantial advancement in the field.

Career Highlights

Yen-Wan Hsiao has worked with prominent organizations such as Genmont Biotech Incorporation and Tunghai University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Yen-Wan Hsiao has collaborated with notable colleagues, including Ming-Shiou Jan and Yi-Hsing Chen. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yen-Wan Hsiao's innovative work in biotechnology, particularly in the areas of pancreatic cancer treatment and antibody development, showcases his dedication to advancing medical science. His contributions through his patents have the potential to make a significant impact in the field.